お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
962199

治療用血漿交換 (TPE) の世界市場の分析 - 製品別 (消耗品、装置)・技術別 (遠心分離、膜分離)・適応症別・エンドユーザー別 (2025年まで):新型コロナウイルス感染症 (COVID-19) の累積的影響

Therapeutic Plasma Exchange Market Research Report by Technology, by Indication, by Product, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.78円
治療用血漿交換 (TPE) の世界市場の分析 - 製品別 (消耗品、装置)・技術別 (遠心分離、膜分離)・適応症別・エンドユーザー別 (2025年まで):新型コロナウイルス感染症 (COVID-19) の累積的影響
出版日: 2021年02月04日
発行: 360iResearch LLP
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の治療用血漿交換 (TPE) の市場規模は、2019年の3億9086万米ドルから、2025年末には6億3422万米ドルへと、8.40%のCAGRで成長すると予測されています。

当レポートでは、世界の治療用血漿交換 (TPE) の市場について分析し、市場の最新動向や促進・抑制要因、全体的な市場規模の動向見通し、製品別・技術別・適応症別・エンドユーザー別および地域別・主要国の詳細動向、市場シェア構造や最新の市場競争動向、主要企業のプロファイル、新型コロナウイルス感染症 (COVID-19) による現在までの累積的影響、といった情報を取りまとめてお届けいたします。

目次

第1章 序論

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場力学

  • イントロダクション
  • 促進要因
    • 慢性疾患の有病率の上昇
    • 治療用血漿交換の活用分野の拡大
    • 治療用血漿交換の多種多様な利用方法
  • 抑制要因
    • 治療用血漿交換の処置・装置の関連費用
  • 市場機会
    • 安価な医療手段へのアクセスの容易化と、医療インフラ開発への政府の関心増大
    • 政府が認可・認定した血液バンクの件数増加
  • 課題
    • 熟練した専門家の人数的制約

第6章 市場の考察

  • ポーターのファイブフォース分析
    • 新規参入企業の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • サプライヤーの交渉力
    • 業界内部の競争状態
  • COVID-19の累積的影響
  • クライアントのカスタマイズ

第7章 世界の治療用血漿交換 (TPE) 市場:製品別

  • イントロダクション
  • 消耗品
  • 装置

第8章 世界の治療用血漿交換 (TPE) 市場:技術別

  • イントロダクション
  • 遠心分離
  • 膜分離

第9章 世界の治療用血漿交換 (TPE) 市場:適応症別

  • イントロダクション
  • 血液疾患
  • 代謝障害
  • 神経障害
  • 腎障害

第10章 世界の治療用血漿交換 (TPE) 市場:エンドユーザー別

  • イントロダクション
  • 採血センター、血液成分プロバイダー
  • 病院・輸血センター

第11章 南北アメリカの治療用血漿交換 (TPE) 市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋の治療用血漿交換 (TPE) 市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第13章 欧州・中東・アフリカ諸国 (EMEA) の治療用血漿交換 (TPE) 市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦 (UAE)
  • 英国

第14章 競合情勢

  • FPNVポジショニング・マトリックス
    • 市場区分
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合シナリオ
    • 企業合併・買収 (M&A)
    • 合意、事業協力・提携
    • 新製品の発売と改良
    • 投資・資金調達
    • 受賞・認証・拡張

第15章 企業のユーザビリティ・プロファイル

  • 旭化成メディカル
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cerus Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Infomed
  • カネカ
  • 川澄化学工業
  • Medica S.p.A.
  • Medicap Clinic GmbH
  • Miltenyi Biotec
  • 日機装
  • NxStage Medical, Inc.
  • Terumo BCT, Inc.

第16章 付録

図表

List of Figures

  • FIGURE 1. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2020 (USD MILLION)
  • FIGURE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: MARKET DYNAMICS
  • FIGURE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (%)
  • FIGURE 16. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2025
  • FIGURE 18. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
  • FIGURE 21. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2025
  • FIGURE 23. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRE SYNDROME, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, 2020 VS 2025 (USD MILLION)
  • FIGURE 33. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, 2020 VS 2025 (USD MILLION)
  • FIGURE 35. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 36. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, 2020 VS 2025 (USD MILLION)
  • FIGURE 38. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, 2020 VS 2025 (USD MILLION)
  • FIGURE 39. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2020 VS 2025 (%)
  • FIGURE 40. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2020 VS 2025 (USD MILLION)
  • FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2025
  • FIGURE 42. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2020 VS 2025 (USD MILLION)
  • FIGURE 43. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, 2020 VS 2025 (USD MILLION)
  • FIGURE 44. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
  • FIGURE 45. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
  • FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2025
  • FIGURE 47. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 48. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 49. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 50. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 52. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 58. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 60. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 65. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 66. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 67. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 68. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 70. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 71. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 72. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 73. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 74. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 75. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 76. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 77. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 78. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 79. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 80. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 81. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 82. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 83. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 84. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 85. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 86. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRE SYNDROME, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: SCORES
  • TABLE 146. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: BUSINESS STRATEGY
  • TABLE 147. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: PRODUCT SATISFACTION
  • TABLE 148. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: RANKING
  • TABLE 149. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: MERGER & ACQUISITION
  • TABLE 150. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 151. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 152. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: INVESTMENT & FUNDING
  • TABLE 153. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 154. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: LICENSE & PRICING
目次
Product Code: MRR-7A58A48

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Therapeutic Plasma Exchange Market is expected to grow from USD 422.80 Million in 2020 to USD 634.22 Million by the end of 2025.

2. The Global Therapeutic Plasma Exchange Market is expected to grow from EUR 370.71 Million in 2020 to EUR 556.09 Million by the end of 2025.

3. The Global Therapeutic Plasma Exchange Market is expected to grow from GBP 329.57 Million in 2020 to GBP 494.37 Million by the end of 2025.

4. The Global Therapeutic Plasma Exchange Market is expected to grow from JPY 45,123.47 Million in 2020 to JPY 67,687.34 Million by the end of 2025.

5. The Global Therapeutic Plasma Exchange Market is expected to grow from AUD 613.96 Million in 2020 to AUD 920.97 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Therapeutic Plasma Exchange to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the Therapeutic Plasma Exchange Market studied across Centrifugation and Membrane Separation.

Based on Indication, the Therapeutic Plasma Exchange Market studied across Hematologic Disorders, Metabolic Disorders, Neurological Disorders, and Renal Disorders. The Hematologic Disorders further studied across Atypical Hemolytic Uremic Syndrome, Hyperviscosity Syndrome, Severe/Symptomatic Cryoglobulinemia, and Thrombotic Thrombocytopenic Purpura. The Neurological Disorders further studied across Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, and PANDAS. The Renal Disorders further studied across Antibody-mediated Renal Transplant Rejection, Goodpasture Syndrome, and Wegener's Granulomatosis.

Based on Product , the Therapeutic Plasma Exchange Market studied across Consumables and Devices.

Based on End-user, the Therapeutic Plasma Exchange Market studied across Blood Collection Centers & Blood Component Providers and Hospitals & Transfusion Centers.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Therapeutic Plasma Exchange Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Therapeutic Plasma Exchange Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Therapeutic Plasma Exchange Market including Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, Fresenius SE & Co. KGaA, Grifols, SA, Haemonetics Corporation, HemaCare, Infomed SA, Kaneka Corporation, Kawasumi Laboratories, Inc., Medica S.p.A., Medicap Clinic GmbH, MEISE Medizintechnik GmbH, Miltenyi Biotec, Nikkiso Co., Ltd., NxStage Medical, Inc., Takeda Pharmaceutical Company Limited, and Terumo BCT, Inc..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Therapeutic Plasma Exchange Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Therapeutic Plasma Exchange Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Therapeutic Plasma Exchange Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Therapeutic Plasma Exchange Market?

4. What is the competitive strategic window for opportunities in the Global Therapeutic Plasma Exchange Market?

5. What are the technology trends and regulatory frameworks in the Global Therapeutic Plasma Exchange Market?

6. What are the modes and strategic moves considered suitable for entering the Global Therapeutic Plasma Exchange Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End-user Outlook
  • 3.4. Technology Outlook
  • 3.5. Indication Outlook
  • 3.6. Product Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the prevalence of chronic diseases
      • 5.1.1.2. Rise in applications of therapeutic plasma exchange
      • 5.1.1.3. Innumerable usages of the therapeutic plasma exchange in the treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Cost associated with the devices and therapeutic plasma exchange procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased government focus on healthcare infrastructure development coupled with easy access to affordable healthcare
      • 5.1.3.2. Increasing number of government licensed and accredited blood banks
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled professionals
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Therapeutic Plasma Exchange Market, By Technology

  • 6.1. Introduction
  • 6.2. Centrifugation
  • 6.3. Membrane Separation

7. Global Therapeutic Plasma Exchange Market, By Indication

  • 7.1. Introduction
  • 7.2. Hematologic Disorders
    • 7.2.1. Atypical Hemolytic Uremic Syndrome
    • 7.2.2. Hyperviscosity Syndrome
    • 7.2.3. Severe/Symptomatic Cryoglobulinemia
    • 7.2.4. Thrombotic Thrombocytopenic Purpura
  • 7.3. Metabolic Disorders
  • 7.4. Neurological Disorders
    • 7.4.1. Chronic Inflammatory Demyelinating Polyneuropathy
    • 7.4.2. Guillain-Barre Syndrome
    • 7.4.3. Multiple Sclerosis
    • 7.4.4. Myasthenia Gravis
    • 7.4.5. PANDAS
  • 7.5. Renal Disorders
    • 7.5.1. Antibody-mediated Renal Transplant Rejection
    • 7.5.2. Goodpasture Syndrome
    • 7.5.3. Wegener's Granulomatosis

8. Global Therapeutic Plasma Exchange Market, By Product

  • 8.1. Introduction
  • 8.2. Consumables
  • 8.3. Devices

9. Global Therapeutic Plasma Exchange Market, By End-user

  • 9.1. Introduction
  • 9.2. Blood Collection Centers & Blood Component Providers
  • 9.3. Hospitals & Transfusion Centers

10. Americas Therapeutic Plasma Exchange Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Therapeutic Plasma Exchange Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. South Korea
  • 11.10. Thailand

12. Europe, Middle East & Africa Therapeutic Plasma Exchange Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis
  • 13.4. Competitor SWOT Analysis
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Asahi Kasei Medical Co. Ltd.
  • 14.2. B. Braun Melsungen AG
  • 14.3. Baxter International Inc.
  • 14.4. Cerus Corporation
  • 14.5. Fresenius SE & Co. KGaA
  • 14.6. Grifols, SA
  • 14.7. Haemonetics Corporation
  • 14.8. HemaCare
  • 14.9. Infomed SA
  • 14.10. Kaneka Corporation
  • 14.11. Kawasumi Laboratories, Inc.
  • 14.12. Medica S.p.A.
  • 14.13. Medicap Clinic GmbH
  • 14.14. MEISE Medizintechnik GmbH
  • 14.15. Miltenyi Biotec
  • 14.16. Nikkiso Co., Ltd.
  • 14.17. NxStage Medical, Inc.
  • 14.18. Takeda Pharmaceutical Company Limited
  • 14.19. Terumo BCT, Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.